[Advantages and inconveniences of inactive and live antipoliomyelitis vaccines].
D000349:Africa; D003906:Developing Countries; D005060:Europe; D006801:Humans; D009656:North America; D011051:Poliomyelitis / Q000517:prevention & control*; D011054:Poliovirus Vaccine, Inactivated / Q000627:therapeutic use*; D011055:Poliovirus Vaccine, Oral / Q000627:therapeutic use*; D012306:Risk; D012922:Social Change; D014613:Vaccines, Attenuated
D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral; D014613:Vaccines, Attenuated
Avantages et inconvénients des vaccins antipoliomyélitiques inactivés et vivants.